SEC Form 4 · accession 0001179110-19-000457
Kala Pharmaceuticals, Inc. · KALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Trachtenberg
Officer — See Remarks
Period of report
Jan 2, 2019
Accepted (ET)
Jan 4, 2019 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479419
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.19 | Jan 2, 2019 | A | 165,000 | A | — | Jan 1, 2029 | Common Stock | 165,000 | 165,000 | D |
Explanation of responses
- F1This option was granted on January 2, 2019 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.
Remarks
General Counsel, Chief Compliance Officer and Secretary. Exhibit List: Exhibit 24 - Power of Attorney.